Tuesday, September 4, 2012

KEEPING YOU IN THE LOOP...Recent Clinical Trial Update

FDA Approves IBS and Constipation Treatment studied in the PMG Network

The FDA has approved Linzess (TM) (linaclotide), a once-daily treatment for adult men and women suffering from Irritable Bowel Syndrome with Constipation (IBS-C) or Chronic Idiopathic Constipation (CIC). Linzess is a capsule taken once daily on an empty stomach, at least 30 minutes before the first meal of the day. Linzess helps relieve constipation by helping bowel movements occur more often. In IBS-C, it may also help ease abdominal pain.

Congratulations to the participants, PMG Sites and Investigators who contributed to the development of a new IBS-C and CIC medication through their participation in this clinical research study!

To learn more, please click here.

No comments :

Post a Comment

Subscribe Via Email